From over‐the‐counter to prescription only: early results of the rescheduling of codeine combination analgesics

• Monash University, Melbourne, VIC

---

• 1. Organisation for Economic Co‐operation and Development. Addressing problematic opioid use in OECD countries (OECD Health Policy Studies). Paris: OECD Publishing, 2019. https://www.oecd.org/health/addressing-problematic-opioid-use-in-oecd-countries-a18286f0-en.htm (viewed Feb 2020).
• 2. Schaffer AL, Cairns R, Brown J, et al. Changes in pharmaceutical sales to pharmacies after codeine was rescheduled a prescription only medicine. Med J Aust 2020; 212: 321–327.
• 3. Harris K, Jiang A, Knoeckel R, Isoardi KZ. Rescheduling codeine‐containing analgesics reduced codeine‐related hospital presentations. Med J Aust 2020; 212: 328.
• 4. Degenhardt L, Gisev N, Cama M, et al. The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol Drug Saf 2016; 25: 521–538.
• 5. Annabel B, Scrymgeour M. Fork handles. Australas J Pharm 2017; 98: 74–75.
• 6. McAllister WB. The global political economy of scheduling: the international–historical context of the Controlled Substances Act. Drug Alcohol Depend 2014; 76: 3–8.
• 7. Derry S, Karlin SM, Moore RA. Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. Cochrane Database Syst Rev 2015; CD010107.
• 8. Daniels SE, Goulder MA, Aspley S, Reader S. A randomised, five‐parallel‐group, placebo‐controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single‐tablet combination of ibuprofen/paracetamol for postoperative dental pain. Pain 2011; 152: 632–642.
• 9. Cock V, Edmonds C, Cock C. Complications related to chronic supratherapeutic use of codeine containing compound analgesics in a cohort of patients presenting for codeine withdrawal. Drug Alcohol Rev 2018; 37: 731–737.
• 10. Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over‐the‐counter codeine‐ibuprofen analgesics: a series of 27 cases. Med J Aust 2010; 193: 294–296. https://www.mja.com.au/journal/2010/193/5/serious-morbidity-associated-misuse-over-counter-codeine-ibuprofen-analgesics
• 11. Mill D, Johnson JL, Cock V, et al. Counting the cost of over‐the‐counter codeine containing analgesic misuse: a retrospective review of hospital admissions over a 5 year period. Drug Alcohol Rev 2018; 37: 247–256.
• 12. Australian Institute of Health and Welfare. Opioid harm in Australia and comparisons between Australia and Canada (Cat. no. HSE 210): data tables (here: table S2.14). Canberra: AIHW, 2018. https://www.aihw.gov.au/getmedia/a7c50ae7-5150-452d-8fcc-d24dcf862e48/aihw-hse-210-data-tables.xlsx.aspx (viewed Jan 2020).
• 13. Australian Department of Health, Therapeutic Goods Administration. Codeine re‐scheduling: regulation impact statement, version 1.1 (Office of Best Practice Regulation no. 19826). Dec 2016. https://www.tga.gov.au/sites/default/files/regulation-impact-statement-codeine-re-scheduling.pdf (viewed Feb 2020).
• 14. Sarantitis I, Gerrard AD, Teasdale R, Pettit S. Small bowel diaphragm disease mimicking malignancy. BMJ Case Rep 2015; bcr2015210174.
• 15. Dang MH, Wu S, Sia C. Ibuprofen‐induced renal tubular acidosis: a rare cause of rhabdomyolysis: a case report. Oxf Med Case Reports 2016; 8: 212–214.
• 16. Robertson CG, Kumar B, Bright T, Watson DI. Beware NSAID abuse: think twice before operating! Aust N Z J Surg 2014; 84: 495–496.
• 17. Cairns R, Scheffer AL, Brown JA, et al. Codeine use and harms in Australia: evaluating the effects of re‐scheduling. Addiction 2020; 115: 451–459.